000			01880 a2200553 4500
005			20250513035945.0
264		0	_c19951019
008			199510s 0 0 eng d
022			_a0140-6736
024	7		_a10.1016/s0140-6736(95)91621-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aHeslop, H E
245	0	0	_aResponse of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1. _h[electronic resource]
260			_bLancet (London, England) _cSep 1995
300			_a805-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntigens, Differentiation _ximmunology
650	0	4	_aB-Lymphocytes _ximmunology
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aDrug Resistance
650	0	4	_aFemale
650	0	4	_aForecasting
650	0	4	_aGlycolipids _ximmunology
650	0	4	_aGraft vs Host Disease _xclassification
650	0	4	_aHumans
650	0	4	_aImmunocompromised Host
650	0	4	_aImmunoglobulin M _xtherapeutic use
650	0	4	_aInfant
650	0	4	_aKiller Cells, Natural _ximmunology
650	0	4	_aLymphocyte Activation _ximmunology
650	0	4	_aMale
650	0	4	_aMembrane Lipids _ximmunology
650	0	4	_aMethylprednisolone _xtherapeutic use
650	0	4	_aRemission Induction
650	0	4	_aT-Lymphocytes _ximmunology
650	0	4	_aTransplantation Immunology
700	1		_aBenaim, E
700	1		_aBrenner, M K
700	1		_aKrance, R A
700	1		_aStricklin, L M
700	1		_aRochester, R J
700	1		_aBilling, R
773	0		_tLancet (London, England) _gvol. 346 _gno. 8978 _gp. 805-6
856	4	0	_uhttps://doi.org/10.1016/s0140-6736(95)91621-0 _zAvailable from publisher's website
999			_c7674178 _d7674178